USDCC Supports Proposed Updates to FDA Donor Eligibility Policy
USDCC was pleased to submit written comments in support of the U.S. Food and Drug Administration's (FDA) draft guidance on Donor Eligibility for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).